Concord Healthcare Group Co., Ltd., a joint stock company incorporated in the People's Republic of China, has announced the placement of new shares under a general mandate. The company's H shares are listed on the Main Board of the Stock Exchange with the stock code 2453. The placement will be completed in accordance with the terms and conditions set out in the Placing Agreement. The process is coordinated by a sole overall coordinator, placing agent, and capital market intermediary. The completion date for the placement is expected to be the second business day after the granting of the Listing Approval, with a final deadline by 5 June 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.